C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases
Severe influenza diseases with high mortality have been frequently reported, especially in those patients infected with avian influenza A (H5N1, H7N9 or H10N8) or during a pandemic. Respiratory distress, which is attributed to alveolar damage associated with immunopathological lesions, is the most c...
Main Authors: | Rongbao Gao, Lijie Wang, Tian Bai, Ye Zhang, Hong Bo, Yuelong Shu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-08-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396417302839 |
Similar Items
-
Correlation of C-reactive protein to severity of symptoms in acute influenza A infection
by: John P Haran, et al.
Published: (2012-01-01) -
Deficiency of C-reactive protein or human C-reactive protein transgenic treatment aggravates influenza A infection in mice
by: Zhuohan Zhang, et al.
Published: (2022-10-01) -
SAA and CRP are potential indicators in distinction and severity assessment for children with influenza
by: Seyin Zou, et al.
Published: (2021-07-01) -
Clinical features and risk factors for severe influenza in children: A study from multiple hospitals in Shanghai
by: Yu Shi, et al.
Published: (2021-07-01) -
Clinical manifestations and risk factors for mortality of patients with severe influenza during the 2016–2018 season
by: Wang-Da Liu, et al.
Published: (2020-06-01)